alexa Antidepressants And Anticonvulsants Analgesic Medications In Pain Management | 6836
ISSN: 2161-1076

Surgery: Current Research
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Antidepressants and Anticonvulsants Analgesic Medications in Pain management

International Conference and Exhibition on Surgery, Anesthesia & Trichology

Foad Elahi

Accepted Abstracts: Surgery Curr Res

DOI: 10.4172/2161-1076.S1.010

The evolution of contemporary clinical pain care dates back to the publication of Melzack and Wall?s gate control theory in the journal Science in 1965. Opioid prescriptions written by primary care practitioners and pain specialists soared, diversion became a very large problem, and deaths and emergency room visits ascribed to opioids esca?lated. There are three basic reasons for considering antidepressant medications for patients with chronic pain. First, psychiatric disorders are common in patients with severe or disabling chronic pain. Second, sleep disturbance is common, even in patients who do not meet criteria for psychiatric disorders. Third, there is evidence that certain classes of antidepressants produce pain relief separate from relief of depression or other psychiatric disorders. As a Pain Specialist I discuss the third reason. Antidepressant analgesia has been well investigated over the past two decades. Pain specialists typically discuss anticonvulsants primarily in relation to neuropathic pain, and the clearest evidence for their efficacy comes from studies of patients with this type of pain. As a first approximation, one could say that anticonvulsants should be used with enthusiasm in patients with neuropathic pain and with caution in patients with other types of pain; unfortunately, this simple rule is beguiling because the boundaries around neuropathic pain are far from clear. Although monotherapy for neuropathic pain has been reported to produce significant benefit for approximately 70% of patients the responses are often partial. As a practical matter, one will commonly encounter patients who continue to complain of significant pain despite trials on anticonvulsants, antidepressants, and other first-line agents. In this setting, combination therapy is a reasonable strategy. Unfortunately, combination therapy involving anticonvulsants has received only minimal attention in research.
Foad Elahi is a graduate from New York Medical College. He has completed one year fellowship in pain medicine. He is currently working as associate professor at the department of anesthesia pain medicine at the University Of Iowa Carver College Of Medicine. His practice fully dedicated to acute and chronic pain management.
Leave Your Message 24x7